Introducing human iPSC derived muscle cells for research and drug discovery

WEBINAR Introducing human iPSC derived muscle cells for research and drug discovery Dr Will Bernard, Senior Scientist (bit.bio), Dr Luke Flatt, Senior Scientist (Charles River) Introducing the first human iPSC-derived skeletal myocyte   Learn how highly-defined...

Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery

TALK Consistent and scalable human iPSC-derived cells for in vitro disease modelling and drug discovery Kam Dhaliwal, SVP Strategic Alliances & Dr Thomas Moreau, Head of Research. 2020. bit.bio talk at ELRIG Listen to our talk at the recent ELRIG conference and...

Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions

TALK Solving the R&D efficiency conundrum within Drug Discovery: Thoughts, Insights and Solutions 2020. bit.bio panel discussion at ELRIG Experienced industry panellists were brought together at ELRIG to engage in a thought-provoking discussion relating to new...

Advances in cellular reprogramming: from stem cells to printed tissues

WEBINAR Advances in cellular reprogramming: from stem cells to printed tissues Prof Hagan Bayley, University of Oxford & Dr Mark Kotter, Founder & CEO bit.bio A scalable technology platform capable of producing consistent batches of every human cell has the...